The University of Cambridge, the Royal College of Physicians, London (RCP) and the Sunway Group have launched a collaborative continuing medical education (CME) seminar series for Malaysian healthcare professionals.
Having supportive family relationships may help youth maintain good asthma management behaviours despite difficult neighbourhood conditions--thus serving as a buffer against poor asthma outcomes associated with living in disorderly neighbourhoods, a recent study finds.
The cut-off value of the STOP-BANG, a simple screening tool for obstructive sleep apnoea (OSA), for neck circumference can be maintained at 40 cm in Asian males but should be lowered to 35 cm in Asian females, according to a Singapore study.
A recently published analysis of the world’s largest genome-wide association study (GWAS) of lung cancer among female never-smokers found a set of tuberculosis (TB)-related genes associated with lung adenocarcinoma in Asian women.
High partial pressure of carbon dioxide (PaCO2) and age, low body mass index (BMI), and previous admission for exacerbations of chronic obstructive pulmonary disease (ECOPD) in the last 2 years strongly predict 90-day mortality in patients with severe COPD, according to the Classification and Regression Tree (CART) analysis of a recent study.
A pulmonary artery diameter to ascending aorta diameter ratio (PA/A) ≥1 during acute exacerbation (AE) is a predictor of poor survival outcomes in patients with fibrotic interstitial lung disease (f-ILD), suggest the results of a recent study.
Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.
The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.